BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36934894)

  • 1. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
    Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
    Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy.
    Yoon S; Cao M; Aghdam N; Shabsovich D; Kahlon S; Ballas L; Collins S; Steinberg ML; Kishan AU
    Radiother Oncol; 2020 Jul; 148():44-50. PubMed ID: 32311600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interfractional Geometric Variations and Dosimetric Benefits of Stereotactic MRI Guided Online Adaptive Radiotherapy (SMART) of Prostate Bed after Radical Prostatectomy: Post-Hoc Analysis of a Phase II Trial.
    Cao M; Gao Y; Yoon SM; Yang Y; Sheng K; Ballas LK; Basehart V; Sachdeva A; Felix C; Low DA; Steinberg ML; Kishan AU
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
    Liu F; Ahunbay E; Lawton C; Li XA
    Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-fractional geometric and dose/volume metric variations of magnetic resonance imaging-guided stereotactic radiotherapy of prostate bed after radical prostatectomy.
    Gao Y; Yoon S; Ma TM; Yang Y; Sheng K; Low DA; Ballas L; Steinberg ML; Kishan AU; Cao M
    Phys Imaging Radiat Oncol; 2024 Apr; 30():100573. PubMed ID: 38585371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
    Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
    Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
    Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
    Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
    Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
    Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of optimal PTV margin for patients receiving CBCT-guided prostate IMRT: comparative analysis based on CBCT dose calculation with four different margins.
    Gill SK; Reddy K; Campbell N; Chen C; Pearson D
    J Appl Clin Med Phys; 2015 Nov; 16(6):252–262. PubMed ID: 26699581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
    Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H
    J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
    Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
    Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.